Evaluation of rotavirus vaccine administration among a 22q11.2DS patient population
22q11.2 Deletion Syndrome (22q11.2DS) can result in array of congenital abnormalities including immune dysfunction. International guidelines recommend immune evaluation of 22q11.2DS patients prior to live vacc...
Source: Allergy, Asthma and Clinical Immunology - Category: Allergy & Immunology Authors: Sophie McGregor, Matthew Boroditsky, Geraldine Blanchard-Rohner, Christine Loock and Kyla Jade Hildebrand Tags: Research Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Microdeletion Syndromes | Rotavirus | Rotavirus Vaccine | Vaccines